- Home
- AMOD vs RPID Comparison
AMOD vs RPID Comparison
Compare AMOD & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMOD
- RPID
- Stock Information
- Founded
- AMOD 2014
- RPID 2006
- Country
- AMOD United States
- RPID United States
- Employees
- AMOD N/A
- RPID N/A
- Industry
- AMOD
- RPID Medical Specialities
- Sector
- AMOD
- RPID Health Care
- Exchange
- AMOD NYSE
- RPID Nasdaq
- Market Cap
- AMOD 35.1M
- RPID 43.5M
- IPO Year
- AMOD N/A
- RPID 2021
- Fundamental
- Price
- AMOD $2.37
- RPID $2.40
- Analyst Decision
- AMOD
- RPID
- Analyst Count
- AMOD 0
- RPID 0
- Target Price
- AMOD N/A
- RPID N/A
- AVG Volume (30 Days)
- AMOD 6.8M
- RPID 278.7K
- Earning Date
- AMOD 01-01-0001
- RPID 02-28-2025
- Dividend Yield
- AMOD N/A
- RPID N/A
- EPS Growth
- AMOD N/A
- RPID N/A
- EPS
- AMOD N/A
- RPID N/A
- Revenue
- AMOD N/A
- RPID $26,170,000.00
- Revenue This Year
- AMOD N/A
- RPID $24.34
- Revenue Next Year
- AMOD N/A
- RPID $19.49
- P/E Ratio
- AMOD N/A
- RPID N/A
- Revenue Growth
- AMOD N/A
- RPID 27.31
- 52 Week Low
- AMOD $1.32
- RPID $0.58
- 52 Week High
- AMOD $13.49
- RPID $2.25
- Technical
- Relative Strength Index (RSI)
- AMOD N/A
- RPID 78.62
- Support Level
- AMOD N/A
- RPID $1.10
- Resistance Level
- AMOD N/A
- RPID $1.49
- Average True Range (ATR)
- AMOD 0.00
- RPID 0.25
- MACD
- AMOD 0.00
- RPID 0.08
- Stochastic Oscillator
- AMOD 0.00
- RPID 94.87
About AMOD ALPHA MODUS HOLDINGS INC
Alpha Modus Holdings Inc is a technology company with a core focus on artificial intelligence in retail. It is engaged in creating, developing and licensing data-driven technologies to enhance consumers' in-store digital experience at the point of decision.
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.